002317 众生药业
已收盘 09-27 15:00:00
资讯
新帖
简况
众生药业(002317.SZ)：目前用于治疗成人单纯性甲型流感的一类创新药物昂拉地韦片已结束III期临床试验入组
市场资讯 · 09-20
众生药业(002317.SZ)：目前用于治疗成人单纯性甲型流感的一类创新药物昂拉地韦片已结束III期临床试验入组
众生药业(002317.SZ)：上半年净利增3.12%至2.09亿元
市场资讯 · 08-21
众生药业(002317.SZ)：上半年净利增3.12%至2.09亿元
众生药业股价站上5日均线，阳包阴能否一扫颓势？看19次回测数据n
同花顺 · 08-11
众生药业股价站上5日均线，阳包阴能否一扫颓势？看19次回测数据n
众生药业：公司鼓励相关疾病领域的基础性研究，暂未参与该项目
证券之星 · 06-06
众生药业：公司鼓励相关疾病领域的基础性研究，暂未参与该项目
众生药业：公司密切关注疾病动态情况，及时做好药品生产和配送工作，目前生产供应正常
证券之星 · 06-05
众生药业：公司密切关注疾病动态情况，及时做好药品生产和配送工作，目前生产供应正常
众生药业(002317.SZ)控股子公司一类创新药ZSP1601片Ⅱb期临床试验完成首例受试者入组
智通财经 · 06-04
众生药业(002317.SZ)控股子公司一类创新药ZSP1601片Ⅱb期临床试验完成首例受试者入组
众生药业最新公告：一类创新药ZSP1601片IIb期临床试验完成首例受试者入组
证券之星 · 06-04
众生药业最新公告：一类创新药ZSP1601片IIb期临床试验完成首例受试者入组
众生药业（002317）6月1日主力资金净卖出3116.58万元
证券之星 · 06-02
众生药业（002317）6月1日主力资金净卖出3116.58万元
众生药业（002317）5月29日主力资金净卖出2.12亿元
证券之星 · 05-30
众生药业（002317）5月29日主力资金净卖出2.12亿元
5月29日众生药业跌5.87%，兴全合润混合(LOF)基金重仓该股
证券之星 · 05-29
5月29日众生药业跌5.87%，兴全合润混合(LOF)基金重仓该股
众生药业（002317）5月25日主力资金净卖出6529.42万元
证券之星 · 05-26
众生药业（002317）5月25日主力资金净卖出6529.42万元
众生药业（002317）5月23日主力资金净买入2.47亿元
证券之星 · 05-24
众生药业（002317）5月23日主力资金净买入2.47亿元
5月23日众生药业（002317）龙虎榜数据：游资赵老哥上榜
证券之星 · 05-23
5月23日众生药业（002317）龙虎榜数据：游资赵老哥上榜
5月23日众生药业涨10.00%，兴全合润混合(LOF)基金重仓该股
证券之星 · 05-23
5月23日众生药业涨10.00%，兴全合润混合(LOF)基金重仓该股
异动快报：众生药业（002317）5月23日9点36分触及涨停板
证券之星 · 05-23
异动快报：众生药业（002317）5月23日9点36分触及涨停板
众生药业：钟院士为来瑞特韦片III期临床研究的总PI
证券之星 · 05-22
众生药业：钟院士为来瑞特韦片III期临床研究的总PI
众生药业(002317.SZ)子公司一类创新药RAY1225注射液Ⅰ期临床试验完成首例受试者入组
智通财经 · 05-19
众生药业(002317.SZ)子公司一类创新药RAY1225注射液Ⅰ期临床试验完成首例受试者入组
众生药业最新公告：控股子公司一类创新药RAY1225注射液Ⅰ期临床试验完成首例受试者入组
证券之星 · 05-19
众生药业最新公告：控股子公司一类创新药RAY1225注射液Ⅰ期临床试验完成首例受试者入组
众生药业(002317.SZ)监事谭珍友亲属短线交易公司股票
智通财经 · 05-18
众生药业(002317.SZ)监事谭珍友亲属短线交易公司股票
龙虎榜 | 光伏股钧达股份2连板，深股通追高；遥望科技跌停，机构抄底
格隆汇 · 05-16
龙虎榜 | 光伏股钧达股份2连板，深股通追高；遥望科技跌停，机构抄底
加载更多
公司概况
公司名称：
广东众生药业股份有限公司
所属行业：
医药制造业
上市日期：
2009-12-11
主营业务：
广东众生药业股份有限公司主营业务是药品研发、生产、销售。公司主要产品有复方血栓通系列产品、众生丸系列产品、头孢克肟分散片、头孢拉定胶囊、硫糖铝口服混悬液。公司为高新技术企业。公司入选“2022中国医药创新企业100强”、“2021年度中国医药工业百强”、“2022年广东省制造业企业500强”。
发行价格：
55.00
{"stockData":{"symbol":"002317","market":"SZ","secType":"STK","nameCN":"众生药业","latestPrice":17.51,"timestamp":1695798201000,"preClose":17,"halted":0,"volume":74667033,"delay":0,"floatShares":723000000,"shares":852999999,"eps":0.3848,"marketStatus":"已收盘","marketStatusCode":5,"change":0.51,"latestTime":"09-27 15:00:00","open":16.88,"high":17.58,"low":16.88,"amount":1296000000,"amplitude":0.0412,"askPrice":17.51,"askSize":2593,"bidPrice":17.5,"bidSize":1302,"shortable":0,"etf":0,"ttmEps":0.3848,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1695864600000},"adr":0,"adjPreClose":17,"symbolType":"stock","highLimit":18.7,"lowLimit":15.3,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":853350477,"pbRate":3.37,"roa":"--","roe":"5.57%","epsLYR":0.4,"committee":-0.349083,"marketValue":14942000000,"floatMarketCap":12656000000,"peRate":45.50416,"changeRate":0.03,"turnoverRate":0.1033,"status":0},"requestUrl":"/m/hq/s/002317","defaultTab":"news","newsList":[{"id":"2368166147","title":"众生药业(002317.SZ)：目前用于治疗成人单纯性甲型流感的一类创新药物昂拉地韦片已结束III期临床试验入组","url":"https://stock-news.laohu8.com/highlight/detail?id=2368166147","media":"市场资讯","top":-1,"share":"https://www.laohu8.com/m/news/2368166147?lang=zh_cn&edition=full","pubTime":"2023-09-20 16:09","pubTimestamp":1695197340,"startTime":"0","endTime":"0","summary":"来源：格隆汇格隆汇9月20日丨众生药业在9月19日投资者关系活动上表示，目前用于治疗成人单纯性甲型流感的一类创新药物昂拉地韦片已结束III期临床试验入组，并收到顶线数据初步统计分析结果：该试验获得了积极结果，本研究已达到方案预设的主要疗效终点指标，且安全性良好。公司将结合项目整体研发进度和研发策略，并参考相关指导原则，适时推进ZSP1273颗粒以及儿童适应症相关临床研究。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2023-09-20/doc-imzniyua2895124.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2023-09-20/doc-imzniyua2895124.shtml","is_publish_highlight":false},{"id":"2361152256","title":"众生药业(002317.SZ)：上半年净利增3.12%至2.09亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2361152256","media":"市场资讯","top":-1,"share":"https://www.laohu8.com/m/news/2361152256?lang=zh_cn&edition=full","pubTime":"2023-08-21 18:11","pubTimestamp":1692612660,"startTime":"0","endTime":"0","summary":"来源：格隆汇格隆汇8月21日丨众生药业(002317.SZ)公布2023年半年度报告，报告期营业收入14.82亿元，同比增长11.80%；归属于上市公司股东的净利润2.09亿元，同比增长3.12%；归属于上市公司股东的扣除非经常性损益的净利润2.29亿元，同比增长22.12%；基本每股收益0.26元。\n\n现在送您60元福利红包，直接提现不套路~~~快来参与活动吧！\n\n\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2023-08-21/doc-imzhycmz2509208.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2023-08-21/doc-imzhycmz2509208.shtml","is_publish_highlight":false},{"id":"2358409053","title":"众生药业股价站上5日均线，阳包阴能否一扫颓势？看19次回测数据n","url":"https://stock-news.laohu8.com/highlight/detail?id=2358409053","media":"同花顺","top":-1,"share":"https://www.laohu8.com/m/news/2358409053?lang=zh_cn&edition=full","pubTime":"2023-08-11 18:39","pubTimestamp":1691750340,"startTime":"0","endTime":"0","summary":"行情显示，众生药业今日出现阳包阴形态，多方力量一举收复失地。点击咨询众生药业如何操作“策略之王”发现， 众生药业出现阳包阴的同时，股价站上5日均线，表示短期多方强势，上涨信号得到了进一步的确认。保守起见，策略哥特地回测了近几年众生药业相同指标形态的出现次数及后续影响，数据发现众生药业从2020年起共出现过19次阳包阴且股价站上5日均线的情况。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2023-08-11/doc-imzfvqmr8853333.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2023-08-11/doc-imzfvqmr8853333.shtml","is_publish_highlight":false},{"id":"2341485520","title":"众生药业：公司鼓励相关疾病领域的基础性研究，暂未参与该项目","url":"https://stock-news.laohu8.com/highlight/detail?id=2341485520","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2341485520?lang=zh_cn&edition=full","pubTime":"2023-06-06 17:51","pubTimestamp":1686045091,"startTime":"0","endTime":"0","summary":"公司正抓紧时间开展ZSP1273片Ⅲ期临床研究的数据整理、锁库揭盲以及数据统计分析工作，该项目尚未进入注册申报阶段。公司鼓励相关疾病领域的基础性研究，暂未参与该项目。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2023060600023840.shtml","is_publish_highlight":false},{"id":"2341042719","title":"众生药业：公司密切关注疾病动态情况，及时做好药品生产和配送工作，目前生产供应正常","url":"https://stock-news.laohu8.com/highlight/detail?id=2341042719","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2341042719?lang=zh_cn&edition=full","pubTime":"2023-06-05 18:21","pubTimestamp":1685960462,"startTime":"0","endTime":"0","summary":"公司公告称甲型流感特效药ZSP1273通用名为昂拉地韦。公司密切关注疾病动态情况，及时做好药品生产和配送工作，目前生产供应正常。经查询，来瑞特韦片目前在京东的售价为698元/盒。众生药业2023一季报显示，公司主营收入7.47亿元，同比上升10.5%；归母净利润1.39亿元，同比上升86.86%；扣非净利润1.28亿元，同比上升1.47%；负债率31.0%，投资收益770.85万元，财务费用291.2万元，毛利率61.49%。该股好公司指标2星，好价格指标2星，综合指标2星。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2023060500016205.shtml","is_publish_highlight":false},{"id":"2340055967","title":"众生药业(002317.SZ)控股子公司一类创新药ZSP1601片Ⅱb期临床试验完成首例受试者入组","url":"https://stock-news.laohu8.com/highlight/detail?id=2340055967","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2340055967?lang=zh_cn&edition=full","pubTime":"2023-06-04 17:47","pubTimestamp":1685872050,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/940304.html","is_publish_highlight":false},{"id":"2340589330","title":"众生药业最新公告：一类创新药ZSP1601片IIb期临床试验完成首例受试者入组","url":"https://stock-news.laohu8.com/highlight/detail?id=2340589330","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2340589330?lang=zh_cn&edition=full","pubTime":"2023-06-04 16:30","pubTimestamp":1685867450,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2023060400000347.shtml","is_publish_highlight":false},{"id":"2340275285","title":"众生药业（002317）6月1日主力资金净卖出3116.58万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2340275285","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2340275285?lang=zh_cn&edition=full","pubTime":"2023-06-02 09:25","pubTimestamp":1685669132,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2023060200010178.shtml","is_publish_highlight":false},{"id":"2339381424","title":"众生药业（002317）5月29日主力资金净卖出2.12亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2339381424","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2339381424?lang=zh_cn&edition=full","pubTime":"2023-05-30 09:29","pubTimestamp":1685410142,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2023053000009295.shtml","is_publish_highlight":false},{"id":"2339419798","title":"5月29日众生药业跌5.87%，兴全合润混合(LOF)基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2339419798","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2339419798?lang=zh_cn&edition=full","pubTime":"2023-05-29 16:36","pubTimestamp":1685349401,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2023052900012142.shtml","is_publish_highlight":false},{"id":"2338471051","title":"众生药业（002317）5月25日主力资金净卖出6529.42万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2338471051","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2338471051?lang=zh_cn&edition=full","pubTime":"2023-05-26 09:24","pubTimestamp":1685064298,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2023052600011882.shtml","is_publish_highlight":false},{"id":"2337119929","title":"众生药业（002317）5月23日主力资金净买入2.47亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2337119929","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2337119929?lang=zh_cn&edition=full","pubTime":"2023-05-24 09:11","pubTimestamp":1684890687,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2023052400010103.shtml","is_publish_highlight":false},{"id":"2337958916","title":"5月23日众生药业（002317）龙虎榜数据：游资赵老哥上榜","url":"https://stock-news.laohu8.com/highlight/detail?id=2337958916","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2337958916?lang=zh_cn&edition=full","pubTime":"2023-05-23 17:12","pubTimestamp":1684833173,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2023052300024734.shtml","is_publish_highlight":false},{"id":"2337379959","title":"5月23日众生药业涨10.00%，兴全合润混合(LOF)基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2337379959","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2337379959?lang=zh_cn&edition=full","pubTime":"2023-05-23 16:43","pubTimestamp":1684831439,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2023052300023490.shtml","is_publish_highlight":false},{"id":"2337985517","title":"异动快报：众生药业（002317）5月23日9点36分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2337985517","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2337985517?lang=zh_cn&edition=full","pubTime":"2023-05-23 09:40","pubTimestamp":1684806034,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2023052300011663.shtml","is_publish_highlight":false},{"id":"2337289536","title":"众生药业：钟院士为来瑞特韦片III期临床研究的总PI","url":"https://stock-news.laohu8.com/highlight/detail?id=2337289536","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2337289536?lang=zh_cn&edition=full","pubTime":"2023-05-22 19:01","pubTimestamp":1684753269,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2023052200016926.shtml","is_publish_highlight":false},{"id":"2336514251","title":"众生药业(002317.SZ)子公司一类创新药RAY1225注射液Ⅰ期临床试验完成首例受试者入组","url":"https://stock-news.laohu8.com/highlight/detail?id=2336514251","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2336514251?lang=zh_cn&edition=full","pubTime":"2023-05-19 19:53","pubTimestamp":1684497206,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/933157.html","is_publish_highlight":false},{"id":"2336511408","title":"众生药业最新公告：控股子公司一类创新药RAY1225注射液Ⅰ期临床试验完成首例受试者入组","url":"https://stock-news.laohu8.com/highlight/detail?id=2336511408","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2336511408?lang=zh_cn&edition=full","pubTime":"2023-05-19 19:20","pubTimestamp":1684495210,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2023051900030418.shtml","is_publish_highlight":false},{"id":"2336304749","title":"众生药业(002317.SZ)监事谭珍友亲属短线交易公司股票","url":"https://stock-news.laohu8.com/highlight/detail?id=2336304749","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2336304749?lang=zh_cn&edition=full","pubTime":"2023-05-18 18:07","pubTimestamp":1684404464,"startTime":"0","endTime":"0","summary":"智通财经APP讯，众生药业(002317.SZ)发布公告，公司于2023年5月18日收到公司监事谭珍友先生出具的《关于本人亲属买卖公司股票构成短线交易的情况说明及致歉函》，获悉其父谭诗文先生于2023年5月9日至5月16日期间买卖公司股票，上述交易构成短线交易。谭诗文先生通过上述短线交易获利共计人民币1080.46元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/932427.html","is_publish_highlight":false},{"id":"2335874547","title":"龙虎榜 | 光伏股钧达股份2连板，深股通追高；遥望科技跌停，机构抄底","url":"https://stock-news.laohu8.com/highlight/detail?id=2335874547","media":"格隆汇","top":-1,"share":"https://www.laohu8.com/m/news/2335874547?lang=zh_cn&edition=full","pubTime":"2023-05-16 17:47","pubTimestamp":1684230460,"startTime":"0","endTime":"0","summary":"龙虎榜净买入额榜前三为钧达股份、深科技、天瑞仪器","market":"hk","thumbnail":"https://img3.gelonghui.com/8341b-165d08b7-a4ae-4e50-8640-de5085998b07.jpg","type":0,"news_type":0,"thumbnails":["https://img3.gelonghui.com/8341b-165d08b7-a4ae-4e50-8640-de5085998b07.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/604527","is_publish_highlight":false}],"profile":{"ret":0,"listingDate":"2009-12-11","address":"广东省东莞市石龙镇西湖工业区信息产业园","stockEarnings":[{"period":"1week","weight":0.1117},{"period":"1month","weight":0.216},{"period":"3month","weight":0.0429},{"period":"6month","weight":-0.1372},{"period":"1year","weight":0.3966},{"period":"ytd","weight":-0.3434}],"companyName":"广东众生药业股份有限公司","boardCode":"AI0027","perCapita":"6248股","boardName":"医药制造业","registeredCapital":"85335万元","compareEarnings":[{"period":"1week","weight":-0.0004},{"period":"1month","weight":0.0028},{"period":"3month","weight":-0.0236},{"period":"6month","weight":-0.0506},{"period":"1year","weight":0.0043},{"period":"ytd","weight":0.0058}],"survey":" 广东众生药业股份有限公司主营业务是药品研发、生产、销售。公司主要产品有复方血栓通系列产品、众生丸系列产品、头孢克肟分散片、头孢拉定胶囊、硫糖铝口服混悬液。公司为高新技术企业。公司入选“2022中国医药创新企业100强”、“2021年度中国医药工业百强”、“2022年广东省制造业企业500强”。","serverTime":1695862778865,"listedPrice":55,"stockholders":"115671人(较上一季度增加11.29%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"CCBot/2.0 (https://commoncrawl.org/faq/)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.17.2","shortVersion":"4.17.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"众生药业(002317)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供众生药业(002317)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"众生药业,002317,众生药业股票,众生药业股票老虎,众生药业股票老虎国际,众生药业行情,众生药业股票行情,众生药业股价,众生药业股市,众生药业股票价格,众生药业股票交易,众生药业股票购买,众生药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"众生药业(002317)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供众生药业(002317)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}